52 research outputs found
Immunopanning purification and long-term culture of human retinal ganglion cells
Purpose: To establish a robust method to isolate primary retinal ganglion cells (RGCs) from human fetal retina for long-term culture while maintaining neuronal morphology and marker protein expression.
Methods: A total of six human retinas were obtained from aborted fetuses at 10 to 12 weeks of gestation with informed consent from mothers. RGCs were isolated and purified by a modified two-step immunopanning procedure. The cells were maintained in a serum-free defined medium supplemented with brain-derived neurotrophic factor, ciliary neutrophic factor, and forskolin. The viable RGCs and the extent of neurite outgrowth were examined by calcein-acetoxymethylester assay. Expression of RGC markers was studied by immunocytochemistry.
Results: Primary RGCs from human fetal retinas were isolated and maintained in vitro for one month with substantial neurite elongation. In cell culture, almost 70% of the isolated cells attached, spread, and displayed numerous dendrites. They were immunoreactive to RGC-specific markers (Thy-1, TUJ-1, and Brn3a) and negative for glial fibrillary acidic protein and amacrine cells marker HPC-1.
Conclusions: Human RGCs were successfully isolated and maintained in long-term culture. This can serve as an ideal model for biologic, toxicological, and genomic assays of human RGCs in vitr
Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cells
Induction of Apoptosis Coupled to Endoplasmic Reticulum Stress in Human Prostate Cancer Cells by n-butylidenephthalide
BACKGROUND: N-butylidenephthalide (BP) exhibits antitumor effect in a variety of cancer cell lines. The objective of this study was to obtain additional insights into the mechanisms involved in BP induced cell death in human prostate cancer cells. METHODS/PRINCIPAL FINDINGS: Two human prostate cancer cell lines, PC-3 and LNCaP, were treated with BP, and subsequently evaluated for their viability and cell cycle profiles. BP caused cell cycle arrest and cell death in both cell lines. The G0/G1 phase arrest was correlated with increase levels of CDK inhibitors (p16, p21 and p27) and decrease of the checkpoint proteins. To determine the mechanisms of BP-induced growth arrest and cell death in prostate cancer cell lines, we performed a microarray study to identify alterations in gene expression induced by BP in the LNCaP cells. Several BP-induced genes, including the GADD153/CHOP, an endoplasmic reticulum stress (ER stress)-regulated gene, were identified. BP-induced ER stress was evidenced by increased expression of the downstream molecules GRP78/BiP, IRE1-α and GADD153/CHOP in both cell lines. Blockage of IRE1-α or GADD153/CHOP expression by siRNA significantly reduced BP-induced cell death in LNCaP cells. Furthermore, blockage of JNK1/2 signaling by JNK siRNA resulted in decreased expression of IRE1-α and GADD153/CHOP genes, implicating that BP-induced ER stress may be elicited via JNK1/2 signaling in prostate cancer cells. BP also suppressed LNCaP xenograft tumor growth in NOD-SCID mice. It caused 68% reduction in tumor volume after 18 days of treatment. CONCLUSIONS: Our results suggest that BP can cause G0/G1 phase arrest in prostate cancer cells and its cytotoxicity is mediated by ER stress induction. Thus, BP may serve as an anticancer agent by inducing ER stress in prostate cancer
Analysis of NQO1 polymorphisms and p53 protein expression in patients with hepatocellular carcinoma
NAD(P)H: quinone oxidoreductase 1
(NQO1), a cytosolic enzyme which catalyzes the twoelectron
reduction of quinone compounds, has been
suggested to prevent the generation of semiquinone free
radicals and reactive oxygen species, thus protecting
cells from oxidative damage. However, the enzymatic
activity of NQO1 strongly depends on the individual
genetic polymorphism of the NQO1 gene. A common
NQO1 polymorphism is a C to T transition at position
609, which results in an inactive enzyme. Recent studies
showed that NQO1 is an important enzyme for
stabilizing p53 protein, which is involved in antitumorigenesis.
Thus, the lack of enzymatic activity in
the homozygous C609T NQO1 polymorphism may play
a pivotal role in tumor development.
This study aimed to investigate the relationship
between C609T NQO1 polymorphism and p53
expression in human hepatocellular carcinoma (HCC).
Genotyping of NQO1 was performed on 100 HCC
specimens by PCR-RFLP analysis. In addition, NQO1
and p53 protein expression in HCC samples at different
TNM stages was determined by immunohistochemistry.
Our data showed that (1) the frequency of C609T NQO1
was significantly increased in TNM stage III HCC
patients; (2) no significant association was found
between p53 expression and C609T polymorphism of
NQO1 gene; and (3) a tumor/non-tumor (T/N) ratio >
1.27 of NQO1 expression revealed by real-time qPCR
analyses was positively correlated with poorer survival
in patients with tumors >5 cm, suggesting that an increase of NQO1 expression may be an indicator of
advanced tumor progression. This study provides
important information about NQO1 genotypes and its
expression to HCC tumor development and progression
Petrology and geochemistry at the Lower zone-Middle zone transition of the Panzhihua intrusion, SW China: Implications for differentiation and oxide ore genesis
A sequence of gabbros showing isotropic, layered and fine-grained textures is exposed in the Nalaqing mine at the southern tip of the ∼260 Ma Panzhihua intrusion, SW China. The field relations, structure, texture and mineralogy of the rocks indicate that the sequence represents the transition between the Lower zone and Middle zone of the intrusion. Isotropic gabbros characteristic of the Lower zone pass upward to layered gabbros of the Middle zone through a ∼5 m-thick microgabbro sheet, within and close to which small-scaled, concordant Fe-Ti oxide ore horizons are identified. Strong fractionation between HFSE and REE in a subset of samples is ascribed to cumulus titanomagnetite into which HFSE are preferentially incorporated over REE, as reflected in the parallel relations between Nb/La, Hf/Sm and Ti/Ti*. Both the isotropic and layered gabbros display cumulate textures and have similar mineral compositions (Mg# of clinopyroxene = ∼76–79 and An59–61), isotopic compositions [(87Sr/86Sr)i = 0.7044–0.7045 and εNd(t) = +2.4 to +3.9] and trapped liquid contents inferred from Zr abundance (∼17–34 ppm). However, there are substantial variations in elemental abundances (V, Cr and PGE) and ratios (Ti/V, La/Yb, Ba/Y and Cu/Pd) between the two types of gabbros, features that cannot be explained by cumulate formation from a common magma in a closed system. The microgabbros generally resemble high-Ti Emeishan basalts in major element compositions, but their low trace element abundances indicate some lost of residual liquid is inevitable despite rapid nucleation and cooling. Combined with available data and observations, we propose a model involving in-situ crystallization, followed by magma recharge and closed-system fractionation to explain the formation of texturally distinctive gabbros at Nalaqing and the evolution of the lower part of the Panzhihua intrusion
Prevalence and Spectrum of p53 Mutations Associated with Smoking in Breast Cancer
To explore the role of smoking in breast cancer, we undertook a population-based study to evaluate the prevalence and spectrum of p53 mutations in the breast tumors of smokers and nonsmokers. We evaluated 456 archival invasive breast tumors for mutations in exons 4-8 of the p53 gene, using single-strand conformational polymorphism analysis and manual sequencing. Statistical analyses were performed to determine the association of p53 mutations with clinical and smoking characteristics. Of 108 mutations identified, 77 (71%) were point mutations and 31 (29%) were deletions or insertions. A higher prevalence of p53 mutations was found in the breast tumors of current smokers (36.5%; P = 0.02) compared with never smokers (23.6%), whereas fewer mutations were found in former smokers (16.2%; P = 0.09). After adjustment for age, race, menopausal status, clinical stage, tumor size, and family history of breast cancer, current smokers were significantly more likely to harbor any p53 mutation [odds ratio (OR), 2.11; 95% confidence interval (CI), 1.17-3.78], p53 transversions (OR, 3.37; 95% CI, 1.03-11.06), and G:C-->T:A transversions (OR, 10.53; 95% CI, 1.77-62.55) compared with never smokers. Stage at diagnosis did not account for the increase in p53 mutation-positive breast cancer among current smokers. Former smokers were also more likely than never smokers to harbor G:C-->T:A transversions (OR, 2.43; 95% CI, 0.37-15.73), although this association was not statistically significant. Among former smokers, the prevalence of p53 mutations varied with time since quitting: former smokers who quit smoking for longer than 1 year had a lower prevalence of p53 mutations (10.5% for 1-5 years and 12.9% for >5 years) than those who had stopped smoking within the year of their cancer diagnosis (26.3%). Our results indicate that cigarette smoking appears to modify the prevalence and spectrum of p53 mutations in breast tumors. Moreover, the difference in mutational spectra observed between smokers and nonsmokers is suggestive of the genotoxic effects of smoking in breast tissue
Comparison of the NucliSens easyMAG and Qiagen BioRobot 9604 Nucleic Acid Extraction Systems for Detection of RNA and DNA Respiratory Viruses in Nasopharyngeal Aspirate Samplesâ–¿
The NucliSens easyMAG and BioRot 9604 automated nucleic acid extraction systems were evaluated and compared with the manual QIAamp (Qiagen) extraction method for their abilities to extract nucleic acid from nasopharyngeal aspirate samples for the detection of RNA and DNA respiratory viruses. The nucleic acids recovered by all three methods gave comparable sensitivities in PCR tests, and the three methods gave comparable viral loads. There was no evidence of residual PCR inhibitors and no evidence of PCR cross-contamination
Prevalence and spectrum of p53 mutations associated with smoking in breast cancer
To explore the role of smoking in breast cancer, we undertook a population-based study to evaluate the prevalence and spectrum of p53 mutations in the breast tumors of smokers and nonsmokers. We evaluated 456 archival invasive breast tumors for mutations in exons 4-8 of the p53 gene, using single-strand conformational polymorphism analysis and manual sequencing. Statistical analyses were performed to determine the association of p53 mutations with clinical and smoking characteristics. Of 108 mutations identified, 77 (71%) were point mutations and 31 (29%) were deletions or insertions. A higher prevalence of p53 mutations was found in the breast tumors of current smokers (36.5%; P = 0.02) compared with never smokers (23.6%), whereas fewer mutations were found in former smokers (16.2%; P = 0.09). After adjustment for age, race, menopausal status, clinical stage, tumor size, and family history of breast cancer, current smokers were significantly more likely to harbor any p53 mutation [odds ratio (OR), 2.11; 95% confidence interval (CI), 1.17-3.78], p53 transversions (OR, 3.37; 95% CI, 1.03-11.06), and G:C-->T:A transversions (OR, 10.53; 95% CI, 1.77-62.55) compared with never smokers. Stage at diagnosis did not account for the increase in p53 mutation-positive breast cancer among current smokers. Former smokers were also more likely than never smokers to harbor G:C-->T:A transversions (OR, 2.43; 95% CI, 0.37-15.73), although this association was not statistically significant. Among former smokers, the prevalence of p53 mutations varied with time since quitting: former smokers who quit smoking for longer than 1 year had a lower prevalence of p53 mutations (10.5% for 1-5 years and 12.9% for >5 years) than those who had stopped smoking within the year of their cancer diagnosis (26.3%). Our results indicate that cigarette smoking appears to modify the prevalence and spectrum of p53 mutations in breast tumors. Moreover, the difference in mutational spectra observed between smokers and nonsmokers is suggestive of the genotoxic effects of smoking in breast tissue
- …